Back
Canopy Growth Vs. Mirum Pharmaceuticals Industry Stock Comparison
Sell
22
CGC
Canopy Growth
Last Price:
6.47
Seasonality Move:
4.16%
Buy
77
MIRM
Mirum Pharmaceuticals
Last Price:
34.15
Seasonality Move:
6.63%
Sell
22
Canopy Growth (CGC)
is a Sell
Is Canopy Growth a Buy, Sell or Hold?
- The current Canopy Growth [CGC] share price is $6.45. The Score for CGC is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- CGC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $34.19. The Score for MIRM is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CGC Stock Price Chart
What is Canopy Growth's stock price today?
-
The Canopy Growth share price today is $6.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGC is experiencing slight selling pressure.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $34.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
CGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.56 | Sell |
| Relative Strength Index (14 RSI): | 34.78 | Sell |
| Chaikin Money Flow: | -661231 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.76 - 8.32) | Sell |
| Bollinger Bands (100): | (4.25 - 9.61) | Sell |
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.24 | Buy |
| Relative Strength Index (14 RSI): | 66.2 | Buy |
| Chaikin Money Flow: | 1534746 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.34 - 31.66) | Buy |
| Bollinger Bands (100): | (24.32 - 29.22) | Buy |
CGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.79 | Sell |
| 20-day SMA: | 7.24 | Sell |
| 50-day SMA: | 8.61 | Sell |
| 200-day SMA: | 6.54 | Sell |
| 8-day EMA: | 6.78 | Sell |
| 20-day EMA: | 7.31 | Sell |
| 50-day EMA: | 7.76 | Sell |
| 200-day EMA: | 8.27 | Sell |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.57 | Buy |
| 20-day SMA: | 28.83 | Buy |
| 50-day SMA: | 26.5 | Buy |
| 200-day SMA: | 28.22 | Buy |
| 8-day EMA: | 32.4 | Buy |
| 20-day EMA: | 29.9 | Buy |
| 50-day EMA: | 27.73 | Buy |
| 200-day EMA: | 27.19 | Buy |
Canopy Growth Earnings Growth & CGC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.02 per share, an increase this year of $6.78 per share, and an increase next year of $1.18 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.34 per share, an increase this year of $1.92 per share, and an increase next year of $1.37 per share.
Canopy Growth Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mirum Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||